+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific Patient-Controlled Analgesic Pumps Market By Type, By Application, By End-use, By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • PDF Icon

    Report

  • May 2021
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5331389
The Asia Pacific Patient-controlled Analgesic Pumps Market is expected to witness market growth of 11% CAGR during the forecast period (2021-2027).

There are various painful conditions in which patient-controlled analgesic pumps are proved to be effective and they are mainly beneficial in acute postoperative pain management. Unique patient-controlled analgesic treatment like PCRA, PCEA, and noninvasive methods of PCA has increased the alternatives for pain-relief treatment. Along with this, the adoption of these methods is expected to be fueled in the next few years due to the developments in PCA technology such as variable-rate infusions that are evaluated on the basis of patient requirements for analgesia and better patient monitoring.

The growth of the market is expected to be supplemented by the integration of the latest technologies in PCA pumps that assists in the quick pain recovery and hence, encourage patients to opt for this device. For example, Acromed Chroma infusion pumps incorporate the new technology in pain management that enables patients to deliver bolus analgesic medicine themselves. This empowers patients to get relief from the pain and enables them to feel comfortable while reducing the requirement for on-site support from hospital members.

The China market dominated the Asia Pacific Specialty Clinics Market by Country in 2020, thereby, achieving a market value of $10,754.7 Thousands by 2027, growing at a CAGR of 8.2% during the forecast period. The Japan market is exhibiting a CAGR of 11.5% during (2021 - 2027). Additionally, The India market is anticipated to witness a prominent CAGR during (2021 - 2027).

Based on Type, the market is segmented into Electronic and Mechanical. Based on Application, the market is segmented into Oncology, Diabetes, Hematology, Gastroenterology and Others. Based on End-use, the market is segmented into Hospitals, Specialty Clinics and Ambulatory Surgical Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Smiths Group PLC, Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Baxter International, Inc., Becton, Dickinson and Company, Terumo Corporation, Abbott Laboratories, Avante Health Solutions, ICU Medical, Inc., and Ace Medical Co., Ltd.

Scope of the Study

Market Segments covered in the Report:

By Type
  • Electronic
  • Mechanical

By Application
  • Oncology
  • Diabetes
  • Hematology
  • Gastroenterology
  • Others

By End Use
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled
  • Smiths Group PLC
  • Fresenius SE & Co. KGaA
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Abbott Laboratories
  • Avante Health Solutions
  • ICU Medical, Inc.
  • Ace Medical Co., Ltd.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Patient-Controlled Analgesic Pumps Market, by Type
1.4.2 Asia Pacific Patient-Controlled Analgesic Pumps Market, by Application
1.4.3 Asia Pacific Patient-Controlled Analgesic Pumps Market, by End Use
1.4.4 Asia Pacific Patient-Controlled Analgesic Pumps Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements,
3.2.2 Geographical Expansions
3.2.3 Approvals & Trials
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
Chapter 4. Asia Pacific Patient-Controlled Analgesic Pumps Market by Type
4.1 Asia Pacific Electronic Market by Country
4.2 Asia Pacific Mechanical Market by Country
Chapter 5. Asia Pacific Patient-Controlled Analgesic Pumps Market by Application
5.1 Asia Pacific Oncology Market by Country
5.2 Asia Pacific Diabetes Market by Country
5.3 Asia Pacific Hematology Market by Country
5.4 Asia Pacific Gastroenterology Market by Country
5.5 Asia Pacific Other Application Market by Country
Chapter 6. Asia Pacific Patient-Controlled Analgesic Pumps Market by End-use
6.1 Asia Pacific Hospitals Market by Country
6.2 Asia Pacific Specialty Clinics Market by Country
6.3 Asia Pacific Ambulatory Surgical Centers Market by Country
6.4 Asia Pacific Home Care Settings Market by Country
Chapter 7. Asia Pacific Patient-Controlled Analgesic Pumps Market by Country
7.1 China Patient-Controlled Analgesic Pumps Market
7.1.1 China Patient-Controlled Analgesic Pumps Market by Type
7.1.2 China Patient-Controlled Analgesic Pumps Market by Application
7.1.3 China Patient-Controlled Analgesic Pumps Market by End-use
7.2 Japan Patient-Controlled Analgesic Pumps Market
7.2.1 Japan Patient-Controlled Analgesic Pumps Market by Type
7.2.2 Japan Patient-Controlled Analgesic Pumps Market by Application
7.2.3 Japan Patient-Controlled Analgesic Pumps Market by End-use
7.3 India Patient-Controlled Analgesic Pumps Market
7.3.1 India Patient-Controlled Analgesic Pumps Market by Type
7.3.2 India Patient-Controlled Analgesic Pumps Market by Application
7.3.3 India Patient-Controlled Analgesic Pumps Market by End-use
7.4 South Korea Patient-Controlled Analgesic Pumps Market
7.4.1 South Korea Patient-Controlled Analgesic Pumps Market by Type
7.4.2 South Korea Patient-Controlled Analgesic Pumps Market by Application
7.4.3 South Korea Patient-Controlled Analgesic Pumps Market by End-use
7.5 Singapore Patient-Controlled Analgesic Pumps Market
7.5.1 Singapore Patient-Controlled Analgesic Pumps Market by Type
7.5.2 Singapore Patient-Controlled Analgesic Pumps Market by Application
7.5.3 Singapore Patient-Controlled Analgesic Pumps Market by End-use
7.6 Malaysia Patient-Controlled Analgesic Pumps Market
7.6.1 Malaysia Patient-Controlled Analgesic Pumps Market by Type
7.6.2 Malaysia Patient-Controlled Analgesic Pumps Market by Application
7.6.3 Malaysia Patient-Controlled Analgesic Pumps Market by End-use
7.7 Rest of Asia Pacific Patient-Controlled Analgesic Pumps Market
7.7.1 Rest of Asia Pacific Patient-Controlled Analgesic Pumps Market by Type
7.7.2 Rest of Asia Pacific Patient-Controlled Analgesic Pumps Market by Application
7.7.3 Rest of Asia Pacific Patient-Controlled Analgesic Pumps Market by End-use
Chapter 8. Company Profiles
8.1 Smiths Group PLC
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Approvals & Trials:
8.2 Fresenius SE & Co. KGaA
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.3 B. Braun Melsungen AG
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.4 Baxter International, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.1 Recent strategies and developments:
8.4.1.1 Approvals & Trials:
8.4.1.2 Acquisition and Mergers:
8.5 Becton, Dickinson and Company
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals & Trials:
8.5.5.2 Acquisition and Mergers:
8.6 Terumo Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.4.2 Approvals & Trials:
8.7 Abbott Laboratories
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Avante Health Solutions
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.9 ICU Medical, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Acquisition and Mergers:
8.9.2.3 Geographical Expansions:
8.10. Ace Medical Co., Ltd.
8.10.1 Company Overview

Companies Mentioned

  • Smiths Group PLC
  • Fresenius SE & Co. KGaA
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Terumo Corporation
  • Abbott Laboratories
  • Avante Health Solutions
  • ICU Medical, Inc.
  • Ace Medical Co., Ltd.

Methodology

Loading
LOADING...